The estimated Net Worth of Edwin Rock is at least $109 Thousand dollars as of 20 June 2024. Edwin Rock owns over 305,000 units of GlycoMimetics Inc stock worth over $108,864 and over the last 2 years Edwin sold GLYC stock worth over $0.
Edwin has made over 4 trades of the GlycoMimetics Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Edwin bought 305,000 units of GLYC stock worth $79,300 on 20 June 2024.
The largest trade Edwin's ever made was buying 305,000 units of GlycoMimetics Inc stock on 20 June 2024 worth over $79,300. On average, Edwin trades about 97,200 units every 83 days since 2022. As of 20 June 2024 Edwin still owns at least 680,403 units of GlycoMimetics Inc stock.
You can see the complete history of Edwin Rock stock trades at the bottom of the page.
Edwin's mailing address filed with the SEC is C/O GLYCOMIMETICS, INC, 9708 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850.
Over the last 11 years, insiders at GlycoMimetics Inc have traded over $15,299,593 worth of GlycoMimetics Inc stock and bought 10,868,557 units worth $48,421,008 . The most active insiders traders include Scott D Sandell, Peter J Barris, and M James Barrett. On average, GlycoMimetics Inc executives and independent directors trade stock every 51 days with the average trade being worth of $38,210. The most recent stock trade was executed by Public Equities, L.P.Invus ... on 7 August 2024, trading 322,361 units of GLYC stock currently worth $61,249.
at glycomimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments. glycomimetics is a clinical-stage biotechnology company. we use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. since the company’s inception in 2003, we have developed a robust, diversified product pipeline. we are a public company traded on the nasdaq under the symbol glyc.
GlycoMimetics Inc executives and other stock owners filed with the SEC include: